Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

Сохранить в:

Библиографические подробности
Опубликовано в::	The New England Journal of Medicine vol. 384, no. 17 (Apr 29, 2021), p. 1589
Главный автор:	Pergola, Pablo E
Другие авторы:	Farag Youssef MK, Agarwal Rajiv, Arnold, Susan, Bako Gabriel, Block, Geoffrey A, Burke, Steven, Castillo, Fausto P, Jardine, Alan G, Khawaja Zeeshan, Koury, Mark J, Lewis, Eldrin F, Lin, Tim, Luo Wenli, Maroni, Bradley J, Matsushita Kunihiro, McCullough, Peter A, Parfrey, Patrick S, Roy-Chaudhury, Prabir, Sarnak, Mark J, Sharma, Amit, Spinowitz Bruce, Tseng, Carol, Tumlin, James, Vargo, Dennis L, Walters, Kimberly A, Winkelmayer, Wolfgang C, Wittes Janet, Eckardt Kai-Uwe
Опубликовано:	Massachusetts Medical Society
Предметы:	Akebia Therapeutics Inc United States > US Hemodialysis Clinical trials Hypoxia-inducible factors Hemoglobin Cerebral infarction Collaboration Kidney diseases Heart failure Hypoxia Myocardial infarction Confidence intervals Erythropoietin Thromboembolism Drug dosages Erythropoiesis Patients Hydroxylase Anemia Heart attacks Prolyl hydroxylase Design Safety Congestive heart failure Dialysis
Online-ссылка:	Citation/Abstract Full Text Full Text - PDF
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Ваш комментарий будет первым!